FTC sues big pharmacy profit managers around insulin prices The company introduced action against Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the record cost of life-saving insulin medicine. Sanders swiftly condemned the transfer in an announcement Wednesday, noting he was dissatisfied but https://labelthefigurewiththeitem52827.theideasblog.com/31118630/the-5-second-trick-for-healthcare-news